Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: A preliminary study in Pakistan

Journal of the College of Physicians and Surgeons Pakistan

Volumn 20, Issue 4, 2010, Pages 246-249

  Mohammed, Nuruddin ^a   Kakal, Fatima ^a   Somani, Mehreen ^a   Zafar, Wajiha ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Cell free fetal DNA; Non invasive pre natal diagnosis; Real time polymerase chain reaction; RhD genotyping

Indexed keywords

BETA GLOBIN; RHESUS D ANTIGEN;

ARTICLE; BLOOD SAMPLING; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMAN; MATERNAL PLASMA; PAKISTAN; PRENATAL DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

BLOOD GROUPING AND CROSSMATCHING; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 77952317272     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RhD genotyping service. Transfusion 2002; 42:1079-85.
2. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sd 2004; 1022:119-123 (Pubitemid 38951591)
3. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, etal. Pre-natal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339:1734-1738 (Pubitemid 28555431)
4. Daniels G, Finning K, Martin P, Summers J. Fetal Wood group genotyping: present and future. Ann NY Acad Sci 2006; 1075:88-95. (Pubitemid 44532769)
5. Ahmed S, Saleem M, Sultana N, Raashid Y, Waqar A, Anwar M, et al Pre-natal diagnosis of beta-thalassaemia in Pakistan: experience in a Muslim country. Prenat Diagn 2000; 20:378-383 (Pubitemid 30261157)
6. Murray JC, Karp LE, Williamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. Am J Med Genet 1983; 16:527-534
7. National Institute for Health and Clinical Excellence (NICE). Routine antenatal anti-D prophylaxis for women who are rhesus D negative. London (UK): National Institute for Health and Clinical Excellence (NICE); 2008.p. 27.
8. Daniels G. Human Mood groups. 2nd ed. Oxford: Blackwell Science; 2002.
9. Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE: the special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn 2008; 28:83-88 (Pubitemid 351311147)
10. Centre for Disease Control and Prevention (CDC). What is EPI info? Geneva: WHO; 2001.
11. Lo YM, Patel P, Wainscoat JS, Sampietro M, Gillmer MD, Fleming KA. Pre-natal sex determination by DNA amplification from maternal peripheral blood. Lancet 1989; 2:1363-5.
12. Comment in: Lancet 1990; 335:1220.
13. Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Kohler M, et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008; 48:2292-2301. Epub 2007 Aug 7.
14. van der Schoot CE, Hahn S, Chitty LS. Non-invasive pre-natal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008; 13:63-68. Epub 2008 Feb 4.
15. Grootkerk-Tax MG, Soussan AA, de Hass M, Maaskant-vanWijk PA, van de Schoot CE. Evaluation of pre-natal RhD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006; 46:2142-2148
16. Gautier E, Benachi A, Giovangrandi Y, Ernault P, Olivi M, Gailkxi T, etal. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005; 192:666-9. Comment in: p. 663-665 (Pubitemid 40311254)
17. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, et al. The presence of an RhD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the RhD-negative blood group phenotype. Blood 2000; 95:12-18 (Pubitemid 30017219)
18. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RhD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336:816-818 (Pubitemid 351548224)
19. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, VIk R. Non-invasive fetal RhD and RHCE genotyping using realtime PCR testing of maternal plasma in RhD-negative pregnancies. J Histocbem Cytocbem 2005; 53:301-305 (Pubitemid 40344062)
20. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF. et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007; 170:941-950
21. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, et al Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive pre-natal diagnosis. Clin Cbem 2006; 52:2211-2218 Epub 2006 Oct 26. (Pubitemid 44924994)